at the end of the day share price performance will depend on profitability of the company, regardless how many drugs being sold or in the pipeline you need to MAKE money.
Investors are keeping on the sideline watching as they have been stung too many times in the past, thinking Mayne Pharma a bargain.
We need just ONE quarter or half of that is profitable, and we move north.
